American Society of Clinical Oncology

SHERPA: White

People

  1. Pandit-Taskar
    Pandit-Taskar
  2. Carrasquillo
    Carrasquillo
  3. Morris
    Morris
  4. Scher
    Scher
  5. Lyashchenko
    Lyashchenko
  6. Lewis
    Lewis
  7. O'Donoghue
    O'Donoghue
  8. Slovin
    Slovin
  9. Rathkopf
    Rathkopf
  10. Martinez
    Martinez

Groups

  1. GSK Faculty (21)
  2. Molecular Imaging and Therapy Service (21)
  3. Molecular Pharmacology and Chemistry Program Faculty (21)
  4. Radiology, Department of (21)
  5. Sloan Kettering Institute Faculty (21)
  6. Department of Medicine (16)
  7. Solid Tumor Oncology Division (15)
  8. Genitourinary Oncology Service (14)
  9. Radiochemistry and Imaging Sciences Service (13)
  10. Medical Physics (12)
Search Within
  1. "Steven Larson"
  2. "Neeta Pandit-Taskar"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (1)
Groups
  1. GSK Faculty (21)
  2. Molecular Imaging and Therapy Service (21)
  3. Molecular Pharmacology and Chemistry Program Faculty (21)
  4. Radiology, Department of (21)
  5. Sloan Kettering Institute Faculty (21)
  6. Department of Medicine (16)

More Groups

People
  1. Neeta Pandit-Taskar (21)
  2. Steven Larson (21)
  3. Jorge Carrasquillo (12)
  4. Howard Scher (11)
  5. Michael Morris (11)
  6. Serge Lyashchenko (10)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (2)
  5. 2017 (1)
  6. 2016 (1)

More Years

Publications
  1. Journal of Clinical Oncology (21)

Results (21)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti–carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)Lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1 dose-escalation trial using convection-enhanced delivery of radiolabeled monoclonal antibody for diffuse intrinsic pontine glioma following external radiation therapy
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J. A.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Donzelli, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase I study of convection-enhanced delivery of (124)I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma: An update with dose-response assessment
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Zhou, Z.; Zanzonico, P.; Donzelli, M.; Lyashchenko, S. K.; Haque, S.; Thakur, S. B.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Intraventricular radioimmunotherapy targeting B7H3 for CNS malignancies
    Meeting Abstract

    Kramer, K.; Pandit-Taskar, N.; Donzelli, M.; Wolden, S. L.; Zanzonico, P.; Humm, J.; Haque, S.; Souweidane, M. M.; Lewis, J.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of convection enhanced delivery (CED) of (124)I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Zanzonico, P.; Zhou, Z.; Donzelli, M.; Lyashchenko, S. K.; Haque, S.; Thakur, S. B.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with (89)Zr-Df-IAB2M in metastatic prostate cancer (PCa)
    Meeting Abstract

    Morris, M. J.; Martinez, D. F.; Durack, J. C.; Slovin, S. F.; Danila, D. C.; O'Donoghue, J. A.; Parada, N. A.; Lyashchenko, S. K.; Carrasquillo, J. A.; Ruan, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Martinez, D. F.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Pathologic correlation of (89)Zr-Df-IAB2M antiprostate-specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer
    Meeting Abstract

    Morris, M. J.; Solomon, S. B.; Durack, J. C.; O'Donoghue, J. A.; Lyashchenko, S. K.; Ruan, S. T.; Carrasquillo, J. A.; Lewis, J. S.; Martinez, D. F.; Parada, N. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; Martinez, D. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save